Penserra Capital Management LLC Legend Biotech Corp Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$41.14 - $56.98 $29,620 - $41,025	-720 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$35.31 - $50.56 $5,296 - $7,584	150 Added 26.32%	720 $36,000
Q2 2021 Aug 12, 2021	BUY	$25.8 - $41.09 $774 - $1,232	30 Added 5.56%	570 $23,000
Q1 2021 May 13, 2021	BUY	$23.55 - $32.4 $1,177 - $1,620	50 Added 10.2%	540 $15,000
Q4 2020 Feb 12, 2021	BUY	$25.8 - $32.39 $12,642 - $15,871	490 New	490 $13,000

205

74.5M

371K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.7B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.